Applied Evidence

10 proven strategies to help patients maintain weight loss

Author and Disclosure Information

 

References

7. Work with patients to ensure sound sleep hygiene

Short sleep duration (< 6 hours a night) is associated with obesity. There are few studies on weight maintenance and sleep; a study that was reviewed by the NWCR found that people who are highly successful at both weight loss and long-term maintenance are more likely to (1) be categorized as a “morning-type” chronotype (ie, getting up early), and (2) report longer sleep duration and better sleep quality, compared to treatment-seeking overweight and obese subjects. Furthermore, these NWCR subjects were more likely to report shorter sleep latency (time required to fall asleep) and were less likely to report short sleep, defined as < 6 to 7 hours a night.21

Counsel patients to eat fewer calories, avoid highly processed foods, and increase protein intake—preferably by preparing food at home.

Patients should strive for 7 to 8 hours of sleep a night; sleep apnea should be addressed as necessary.17 It is important for doctors to encourage patients to go to bed and get up at the same times every day (eg, 10 pm to 6 am daily).

8. Start a trial of medical therapy

Weight-loss medicines are beyond the scope of this article but worth discussing. In accordance with obesity guidelines, if a patient responds well to a weight-loss medication and loses ≥ 5% of body weight after 3 months, continue prescribing the medication. If the medication is ineffective or the patient experiences adverse effects, stop the prescription and consider an alternative medication or approach to maintenance.

The US Food and Drug Administration has approved 5 medications for long-term use in weight maintenance: the 2 combination formulations bupropion–naltrexone and phentermine–topiramate, as well as liraglutide, lorcaserin, and orlistat. A review of the use of these drugs over 1 year showed that they provide a modest favorable effect on cardiometabolic outcomes that vary by drug class.22 In particular, liraglutide has been shown to reduce the risk of cardiovascular disease outcomes in patients with diabetes who have a history of atherosclerotic disease or heart attack and stroke.23 Further research is needed to evaluate the long-term impact of these drugs on cardiovascular risk.

9. Address mental health challenges

Certain personal traits and behaviors appear to help people lose weight: In a study, maintainers were more likely to be characterized as being good problem-solvers, having hope, and having a more positive mood.24,25

Continue to: Addressing mental health issues...

Pages

Recommended Reading

Nearly 25% of U.S. adults take an obesogenic prescription drug
MDedge Family Medicine
Score predicts bariatric surgery’s benefits for obesity, type 2 diabetes
MDedge Family Medicine
Bariatric surgery candidates show high prevalence of thrombophilia
MDedge Family Medicine
Evidence builds for bariatric surgery’s role in cancer prevention
MDedge Family Medicine
Diabetes boosts bariatric surgery complications
MDedge Family Medicine
FDA warns of possible cancer risk with lorcaserin
MDedge Family Medicine
Bariatric surgery is most effective early in the diabetes trajectory
MDedge Family Medicine
Fewer interventions after sleeve gastrectomy vs. Roux-en-Y, real-world data show
MDedge Family Medicine
Age, race affect preterm birth risk in women with obesity
MDedge Family Medicine
Bariatric surgery lacks impact on teens’ long-term mental health
MDedge Family Medicine